Peripheral naive T lymphocytes are considered quiescent, a state thought to be due to a lack of activation signals. Growing evidence, however, suggests that T cell quiescence does not occur by default but is actively maintained by both intrinsic and extrinsic mechanisms 1,2 . Antigen stimulation can drive quiescent naive T cells to undergo proliferation and gain effector functions, but these same changes can occur without overt antigen challenge in circumstances such as lymphopenia or after ablation of either inhibitory receptors or regulatory T cells [3] [4] [5] [6] [7] [8] . To a large extent, the molecular mechanisms that underlie naive T cell quiescence, especially at the transcriptional level, are poorly understood.
A r t i c l e s
Peripheral naive T lymphocytes are considered quiescent, a state thought to be due to a lack of activation signals. Growing evidence, however, suggests that T cell quiescence does not occur by default but is actively maintained by both intrinsic and extrinsic mechanisms 1, 2 . Antigen stimulation can drive quiescent naive T cells to undergo proliferation and gain effector functions, but these same changes can occur without overt antigen challenge in circumstances such as lymphopenia or after ablation of either inhibitory receptors or regulatory T cells [3] [4] [5] [6] [7] [8] . To a large extent, the molecular mechanisms that underlie naive T cell quiescence, especially at the transcriptional level, are poorly understood.
The survival of naive T cells involves both engagement of the T cell antigen receptor (TCR) and stimulation of the IL-7 receptor (IL-7R), which indicates that in a quiescent state, these cells require constant subthreshold signals to persist [9] [10] [11] . Lymphopenia-induced proliferation of naive T cells also requires signals from TCR and IL-7R 3, 4, [9] [10] [11] . TCR stimulation can trigger three mitogen-activated protein kinase pathways: the extracellular signal-regulated kinase (Erk) pathway; the c-Jun NH 2 -terminal kinase (Jnk) pathway; and the p38 pathway [12] [13] [14] . Differences in the activation of these signaling pathways lead to distinct functional outcomes in T cell development and activation 15, 16 . Less Erk activity affects both thymocyte maturation and the activation of peripheral mature T cells [15] [16] [17] . IL-7R is also critical for thymocyte development, the survival of naive T cells and homeostasis [9] [10] [11] 18, 19 . The IL-7R complex is composed of an IL-7R α-chain (IL-7Rα) and the common cytokine receptor γ-chain, but the control of IL-7 signaling is regulated mainly by IL-7Rα expression 20 . Several transcription factors and an enhancer regulatory element are known to control IL-7Rα expression in T lineage cells [21] [22] [23] [24] . Despite those findings, the nature of the combinatorial signals from TCR and IL-7R and their regulation in naive T cell quiescence and lymphopenia-induced proliferation remain unclear 10, 11 . In particular, little is known about cell-intrinsic transcriptional regulation that may actively dampen such signals and prevent peripheral T cells from being spontaneously activated.
The forkhead box (Fox) proteins constitute a large transcription factor family with diverse functions [25] [26] [27] . Foxo1 has a critical role in regulating IL-7Rα expression and T cell homeostasis 28, 29 . The activated phenotype of Foxo1-deficient T cells seems to be mainly due to secondary, lymphopenia-induced proliferation after more apoptosis of Foxo1-deficient T cells 28, 29 . Foxp1, a member of the 'Foxp' subfamily, is expressed in many tissues and is a critical transcriptional regulator in B lymphopoiesis [30] [31] [32] . Conditional deletion of Foxp1 at the CD4 + CD8 + double-positive (DP) thymocyte stage has proven that Foxp1 is essential for the generation of quiescent naive T cells during thymocyte development 33 .
In this study, we circumvented abnormal thymocyte development and studied the function of Foxp1 in mature T cells through the use of an inducible deletion model system. We found that mature naive CD8 + T cells lacking Foxp1 gained effector phenotype and function and proliferated directly in response to IL-7 in vitro. We further demonstrated that Foxp1 antagonized Foxo1 for binding to the same forkhead-binding site in the IL-7Rα enhancer region. By negatively regulating IL-7Rα expression and signaling by MEK and Erk, Foxp1 exerted essential cell-intrinsic transcriptional regulation of the quiescence and homeostasis of mature naive T cells.
RESULTS

Foxp1-deficient naive CD8 + T cells proliferate in response to IL-7
To study Foxp1 function in mature T cells, we generated Foxp1 f/f Cre-ERT2 + Rosa YFP mice in which Cre recombinase becomes activated by treatment with tamoxifen 34 Nondividing  (IL-7)   100  80  60  40  20  0   100  80  60  40  20  0   100  80  60  40  20  0   100  80  60  40  20  0   100  80  60  40  20  0   10 5  10 4  10   3   10   2   0   10   5   10 4  10 3  10   2   0  10 5  10 4  10 3  10 2  0  10 5  10 4  10 3 Fig. 1a ) in the culture by day 6. Without IL-7, most cells died in the culture (data not shown).
In contrast, in cultures with tamoxifen and IL-7, YFP + cells started to emerge around day 2 (data not shown). By day 6, in contrast to YFP -cells, most YFP + cells proliferated, upregulated their expression of CD44 and CD25, slightly downregulated CD62L and increased in size (Fig. 1b) . We also observed such phenotypic changes, although to a lesser extent, in nondividing YFP + cells (Fig. 1b) Fig. 1b-c) . This indicated that complete deletion of Foxp1 in CD8 + T cells was required for the phenotypic changes we observed. These changes occurred by day 6 only in cultures treated with IL-7, but not in those treated with IL-4 (or IL-15; Fig. 1b and data not shown), although there was equally efficient deletion of Foxp1 and induction of YFP + cells in all cultures by day 4 ( Supplementary Fig. 1b,d ).
Functional analysis showed that stimulation with phorbol 12-myristate 13-acetate (PMA) plus ionomycin induced a greater frequency of IFN-γ-and IL-2-producing YFP + cells than IFN-γ-and IL-2-producing YFP -T cells (Fig. 1c) . We also observed such functional changes in nondividing YFP + cells (Fig. 1c) , which indicated that both the phenotypic changes and functional changes in YFP + cells were induced without proliferation. The proliferation of YFP + cells in response to IL-7 was not due to contamination by CD44 hi CD8 + T cells during the sorting of CD44 lo CD8 + T cells from the mice, because YFP + cells from cultures of CD44 lo CD8 + T cells proliferated much more than did YFP -cells from cultures of sorted CD44 hi CD8 + T cells (Fig. 1b,d) . YFP + cells from cultures of sorted CD44 hi CD8 + T cells also proliferated substantially and upregulated CD25 expression (Fig. 1d) .
To further confirm that Foxp1-deficient naive CD8 + T cells proliferated in response to IL-7, we sorted CD44 lo CD8 + T cells from Foxp1 f/f Cre-ERT2 + Rosa YFP mice and control wild-type littermates (Foxp1 f/f Rosa YFP mice) and cultured them for 2 d, then sorted YFP + and wild-type control cells and cultured them in equal numbers with IL-7 alone. Because we noted deletion of Foxp1 in some YFP -T cells from Foxp1 f/f Cre-ERT2 + Rosa YFP mice after tamoxifen treatment (data not shown), we used cultured wild-type T cells as controls in this set of experiments (for the same reason, we used congenic wild-type controls in the in vivo transfer experiments described below). By day 6, YFP + cells proliferated more, which resulted in more total cells and higher granzyme B expression than that of wild-type control cells ( Supplementary Fig. 2a-c) . These results suggest that the deletion of Foxp1 leads mature naive CD8 + T cells to gain both effector phenotype and function and proliferate in response to IL-7 in the absence of overt TCR stimulation. Mature naive CD4 + T cells in which Foxp1 was acutely deleted gained effector phenotype and function as well (albeit to a much lesser extent than did CD8 + T cells) but did not proliferate in response to IL-7 or IL-4 in vitro (Supplementary Fig. 3a-c) .
Foxp1 represses IL-7Ra expression
The proliferation of Foxp1-deficient naive CD8 + T cells in response to IL-7 prompted us to investigate IL-7Rα expression. Because IL-7 was required for in vitro culture and IL-7 downregulated IL-7Rα expression 36 (data not shown), we assessed IL-7Rα expression in T cells from mice with both loxP-flanked Foxp1 alleles and expression of Cre driven by Cd4 (Foxp1 f/f Cd4-Cre mice). We found that IL-7Rα expression was higher in Foxp1-deficient CD4 + and CD8 + singlepositive thymocytes and peripheral T cells than in wild-type control cells (Fig. 2a) . IL-7Rα expression was also higher in Foxp1-deficient T cells in mixed-bone marrow chimeras of lethally irradiated intact recipient mice reconstituted with T cell-depleted bone marrow from Foxp1 f/f Cd4-Cre and Foxp1 +/+ Cd4-Cre mice (Supplementary Fig. 4a ), which indicated cell-intrinsic control of IL-7Rα expression by Foxp1. In addition, we found enhanced phosphorylation of the transcription factor STAT5 in activated Foxp1-deficient CD4 + T cells cultured with IL-7 ( Supplementary Fig. 4b ), which suggested that the higher IL-7Rα expression in Foxp1-deficient T cells was functional. Ex vivo, Foxp1-deficient T cells had higher expression of Il7r mRNA than did wild-type control cells (Fig. 2b) . We transduced retrovirus expressing Foxp1A, the dominant Foxp1 isoform in T lineage cells 33 , into T cells in vitro. During the first 2 d of TCR stimulation, IL-7Rα expression was downregulated in both Foxp1-deficient T cells and A r t i c l e s control T cells (Fig. 2c) . By day 4, Foxp1A repressed IL-7Rα expression in both Foxp1-deficient and wild-type control T cells relative to its expression in T cells infected with control retrovirus (Fig. 2c) . Thus, although the acute downregulation of IL-7Rα by TCR stimulation is not Foxp1 dependent, Foxp1 represses IL-7Rα expression in both CD4 + T cells and CD8 + T cells.
Foxp1 antagonizes Foxo1 in the regulation IL-7Ra expression
Bioinformatics analysis identified three forkhead-binding sites with high scores in the Il7r locus, with one in the Il7r enhancer region 23, 28, 29 ( Fig. 3a) . By electrophoretic mobility-shift assay (EMSA), we found that Foxp1A translated in vitro bound specifically to the Il7r enhancer fragment containing the predicted forkhead-binding site (Fig. 3b) . Binding was inhibited by competition with an identical unlabeled oligonucleotide but not by competition with an irrelevant oligonucleotide. Binding was also inhibited by mutation of the forkheadbinding site. The mobility of the DNA-protein complex shifted after the addition of a Foxp1-specific antibody but not after the addition of control antibodies (Fig. 3b) .
Chromatin-immunoprecipitation (ChIP) assay of Foxp1 in mature wild-type T cells also showed that Foxp1 bound specifically to the Il7r enhancer region (Fig. 3c) , which suggested that IL-7Rα is probably a direct target of Foxp1. Foxo1 is known to upregulate IL-7Rα expression by binding to the same Il7r enhancer region 28, 29 . We did not find an overall increase in Foxo1 protein, or its accumulation in the nucleus, in Foxp1-deficient T cells ( Fig. 3d and data not shown), which suggested that the higher IL-7Rα expression in Foxp1-deficient T cells was probably not due to higher Foxo1 expression.
Our EMSA showed that Foxo1 bound to the same forkhead-binding site in the Il7r enhancer region as Foxp1 did (Supplementary Fig. 5a ). To address how Foxp1 and Foxo1 interact to control IL-7Rα enhancer activity, we transiently transfected EL4 mouse lymphoma cells with an Il7r enhancer-luciferase reporter construct 23 . In this context, when tested either alone or together, Foxp1 and Foxo1 had only marginal effects on the Il7r enhancer reporter (data not shown). We were unable to distinguish whether additional cofactors are necessary or whether the antagonism between Foxp1 and Foxo1 can be observed only in the context of native chromatin.
To further address how these two transcription factors interact on the Il7r enhancer, we generated Foxp1 f/f Foxo1 f/f mice and deleted both Foxp1 and Foxo1 in T cells by in vitro retroviral expression of Cre recombinase (with green fluorescent protein (GFP) as a reporter Fig. 3e,f) . The amount of IL-7Rα was similar in uninfected (GFP -) T cells in control and Cre-expressing retroviral cultures (Supplementary Fig. 5b ). IL-7Rα expression was slightly higher in GFP + Foxp1 f/f T cells infected with Cre-expressing retrovirus than in their GFP + counterparts infected with control retrovirus but was much lower in GFP + Foxo1 f/f T cells (Fig. 3e) . IL-7Rα expression was similar in GFP + Foxp1 f/f Foxo1 f/f T cells infected with control retrovirus and those infected with Cre-expressing retrovirus (Fig. 3e) . These data suggest that the downregulation of IL-7Rα expression in Foxo1-deficient T cells is Foxp1 dependent and that Foxp1 is a repressor of IL-7Rα expression.
IL-7R in the proliferation of CD8 + T cells
To determine how the amount of IL-7Rα regulates CD8 + T cell proliferation, we took advantage of the differences between wild-type Il7r +/+ T cells and heterozygous Il7r +/− T cells in their expression of IL-7Rα (Fig. 4a) and generated Foxp1 f/f Cd4-Cre Il7r +/− mice. IL-7Rα expression in Foxp1 f/f Cd4-Cre Il7r +/− T cells was as low as its expression in normal wild-type (Il7r +/+ ) T cells (Fig. 4a) . We cultured purified CD8 + T cells from Il7r +/+ , Il7r +/− , Foxp1 f/f Cd4-Cre Il7r +/+ and Foxp1 f/f Cd4-Cre Il7r +/− mice with IL-7 in vitro. By day 3, only Foxp1-deficient CD8 + T cells proliferated, in a manner dependent on the concentration of IL-7R and IL-7 (Fig. 4b,c and  Supplementary Fig. 6a) .
Although lower IL-7R expression did not correct the abnormal activated phenotype of Foxp1-deficient T cells from Foxp1 f/f Cd4-Cre mice (Supplementary Fig. 6b ), almost no CD44 hi CD8 + T cells sorted from Il7r +/+ and Il7r +/− mice proliferated in response to IL-7 (Fig. 4d) , which suggested that Foxp1-deficient CD8 + T cells proliferated in response to IL-7 because of the Foxp1 deletion and not because of the activated status. To circumvent the issue of the activated cell status and determine whether IL-7R is essential, we generated Foxp1 f/f Cre-ERT2 + Rosa YFP Il7r +/− mice in which the IL-7R expression in naive CD8 + T cells was about 60% of its expression in Foxp1 f/f Cre-ERT2 + Rosa YFP Il7r +/+ control cells (Fig. 4e and data not shown) . The lower IL-7R expression alone was sufficient to substantially impair the proliferation and some of the phenotypic changes of naive CD8 + T cells in response to IL-7 after deletion of Foxp1 (Fig. 4f) . These results suggest that the amount of IL-7R is critical for the proliferation of naive Foxp1-deficient CD8 + T cells in response to IL-7 in vitro. 
A r t i c l e s
Foxp1 negatively regulates signaling by MEK and Erk Adjustment of IL-7Rα expression to nearly wild-type amounts did not completely prevent the IL-7-induced proliferation of Foxp1-deficient CD8 + T cells, which suggested that in addition to regulating IL-7R, Foxp1 regulates some other molecule(s) critical for the proliferation of CD8 + T cells ex vivo in response to IL-7. In Foxp1 f/f Cd4-Cre mice, Foxp1 starts to be deleted in DP thymocytes, but analyses of cell numbers and expression of cell surface markers (including TCRβ and CD3) have indicated that Foxp1-deficient DP thymocytes seem to be normal 33 . Because the overall activated phenotype of Foxp1-deficient T cells indicated a potential role in TCR signaling, we investigated the activation of MEK, Erk, Jnk and p38 in DP thymocytes. We found that the activation of Jnk and p38 was similar in Foxp1-deficient and wild-type control DP thymocytes, but the activation of MEK and Erk was enhanced in Foxp1-deficient DP thymocytes (Fig. 5a) . Notably, IL-7Rα was not expressed in DP thymocytes (Fig. 2a) ; thus, the regulation of MEK signaling and Erk signaling by Foxp1 was independent of the effect of Foxp1 on IL-7Rα. We also examined Erk activation in mature T cells and found that by day 4 of in vitro culture, Erk phosphorylation was greater in YFP + CD8 + T cells from Foxp1 f/f Cre-ERT2 + Rosa YFP mice than in wildtype control cells both before and after TCR stimulation (Fig. 5b) . The addition of U0126, a chemical inhibitor specific for MEK1 and MEK2, resulted in much less proliferation of Foxp1-deficient naive CD8 + T cells in response to IL-7, but the addition of SB203580, a chemical inhibitor specific for p38, did not (Fig. 5c) . These results suggest that MEK and Erk, but not the p38 signaling pathway, are involved in the Foxp1-regulated proliferation of naive CD8 + T cells in response to IL-7 in the absence of overt TCR stimulation.
Foxp1 regulates T cell quiescence and homeostasis in vivo
To examine how Foxp1 regulates naive T cell quiescence and homeostasis in vivo, and to avoid potential secondary effects due to the deletion of Foxp1 in non-T cells after tamoxifen treatment in vivo, we used an adoptive-transfer model system. We mixed CD44 lo CD8 + or CD4 + T cells sorted from Foxp1 f/f Cre-ERT2 + Rosa YFP and control CD45.1 + congenic wild-type mice and labeled the cells with the fluorescent dye CellTrace, then transferred them together into intact recipient mice, which received tamoxifen treatment 1 d before the transfer and for the first 3 d after transfer. At 8 d after transfer, most of the YFP + cells in the recipient mice upregulated their expression of IL-7Rα and CD44 but did not proliferate (Fig. 6a and data not shown) . A higher percentage of YFP + cells than wild-type control cells produced IFN-γ and/or IL-2 after stimulation with PMA plus ionomycin (Fig. 6b) . At 15 d after transfer, the deletion of Foxp1 induced the proliferation of a substantial fraction of CD8 + and CD4 + T cells (Fig. 6c) . In recipient mice that did not receive any tamoxifen treatment, we detected no proliferation of either Foxp1 f/f Cre-ERT2 + Rosa YFP T cells or wild-type control T cells at 15 d after transfer (data not shown). These results suggest that Foxp1 is critical for the maintenance of quiescence in both naive CD8 + and CD4 + T cells in lympho-replete mice.
The proliferation of Foxp1-deficient naive CD8 + T cells in response to IL-7 in vitro occurred without TCR stimulation (Fig. 1) . To determine whether TCR engagement is important for the regulation of naive T cell quiescence and homeostasis by Foxp1 in vivo, we mixed CD44 lo CD8 + T cells sorted from Foxp1 f/f Cre-ERT2 + Rosa YFP and control CD45.1 + congenic wild-type mice, labeled the cells with CellTrace and cultured them for 2 d with tamoxifen in medium. These conditions ensured deletion of Foxp1 before the transfer of cells and subsequent proliferation in the lymphopenic environment of sublethally irradiated mice deficient in H-2K b and H-2D b . At 7 d after transfer, whereas most of the wild-type control cells did not proliferate, many more Foxp1-deficient naive CD8 + T cells proliferated and upregulated CD44 expression in recipient mice deficient in H-2K b and H-2D b (Fig. 7a,b) . We obtained similar results in parallel experiments in which we first transferred cells into irradiated mice deficient in H-2K b and H-2D b , then treated the recipient mice with tamoxifen in vivo (Supplementary Fig. 7a,b) . However, in recipient mice deficient in recombination-activating gene 1, Foxp1-deficient CD8 + T cells proliferated only slightly more than wild-type control cells did (data not shown), which indicated that the enhanced proliferation of Foxp1-deficient CD8 + T cells in lymphopenia was less notable when complexes of self peptide and major histocompatibility complex were available. Nevertheless, inhibition of IL-7R signaling with antibody to IL-7 and antibody to IL-7R almost completely blocked the proliferation of Foxp1-deficient CD8 + T cells in recipient mice deficient in H-2K b and H-2D b (Fig. 7c) . These results suggest that in lymphopenic conditions and in the absence of (or in the presence of considerably less) engagement of the TCR with complexes of self peptide and major histocompatibility complex, Foxp1 is essential for naive T cell quiescence and homeostasis and that this regulation is dependent on IL-7-IL-7R.
DISCUSSION
The mechanisms that maintain T cell quiescence and homeostasis need to be understood, as they control the balance between eliciting strong immune responses against pathogens and maintaining immunological tolerance to prevent autoimmunity. KLF2, a zinc-finger transcription factor, and Tob, a nuclear protein of the antiproliferative APRO family, have been reported to be important in the regulation of T cell quiescence [37] [38] [39] . Subsequent studies, however, have shown that KLF2 seems to regulate the migration rather than the quiescence of T cells 40, 41 , and spontaneous T cell activation has not been reported in Tob-deficient mice 1, 42 . In our study here, we have provided direct evidence that Foxp1 has an indispensable role in maintaining naive T cell quiescence, in part by repressing IL-7Rα expression. Foxp1 and Foxo1 have been shown to upregulate the expression of recombination-activating genes during early B cell development by binding to the same 'Erag' enhancer region 32, 43 . However, neither transcription factor seems to regulate these genes in T lineage cell development 32, 43 . Foxo1 affects IL-7Rα expression in early B lineage cells 44 , but deletion of Foxp1 does not affect IL-7Rα expression in pro-B cells 32 . These results suggest that Foxp1 and Foxo1 may interact in complex and distinct ways in different parts of the immune system. Depending on their interaction with other transcription factor families or various cofactors, Foxo proteins can alter transcriptional regulation by a variety of mechanisms 27 . It is likely that Foxp1 and Foxo1 act together with other cofactors to exert their functions. As Foxo1 targets many genes encoding molecules involved in important cellular processes, such as the cell cycle and metabolism [25] [26] [27] , further studies are needed to provide a complete picture of the relationship between Foxp1 and Foxo1 (and other Foxo proteins) in regulating T cell quiescence and homeostasis and other important cellular functions.
In addition to regulating IL-7Rα expression, Foxp1 seems to control other molecules critical for regulating T cell quiescence. Our results have shown that Foxp1 negatively regulates the MEK-Erk pathway. Transgenic mice expressing the oncogenic protein K-Ras develop T cell lymphoma and/or leukemia characterized by aberrantly high CD44 expression in thymocytes 45 , which is consistent with the activated phenotype of Foxp1-deficient thymocytes 33 . We attempted to introduce a dominant negative K-Ras to inhibit MEK-Erk signaling and determine whether it could restore the activated phenotype of Foxp1-deficient T cells in Foxp1 f/f Cd4-Cre mice. However, the dominant negative K-Ras almost completely blocked T cell development (data not shown). Nonetheless, we found that blocking MEK-Erk activation impaired the proliferation of Foxp1-deficient naive CD8 + T cells in response to IL-7 in vitro.
It has been shown that the MEK-Erk pathway can be regulated by IL-7R and signaling pathways other than TCR signaling 46, 47 . Because Foxp1-deficient CD8 + T cells in which IL-7Rα expression was adjusted to nearly wild-type amounts still proliferated in response to IL-7 (whereas wild-type CD8 + T cells did not), blocking MEK-Erk activation probably inhibits pathways regulated by Foxp1, but independently of IL-7R-signaling. It has been proposed that constitutive low-intensity TCR signaling, independently of receptor ligation, has an important role in T cell development, and low Erk kinase activity is part of the TCR basal signaling 48, 49 . Therefore, although the proliferation of Foxp1-deficient naive CD8 + T cells in response to IL-7 in vitro and in lymphopenic mice deficient in H-2K b and H-2D b in vivo would indicate that there is no obvious TCR engagement, Foxp1 may regulate a basal TCR signal involving MEK-Erk activity. It is possible that in the absence of Foxp1, the integration of both enhanced IL-7R and basal TCR signals act together to drive the naive T cells to proliferate. The nature and role of basal TCR signaling in mature T cells remain unknown. Further studies are needed to address how MEK-Erk signaling is involved in the Foxp1 regulation of T cell quiescence in the absence of overt TCR stimulation.
Naive CD4 + T cells with acute deletion of Foxp1 did not proliferate in response to IL-7 in vitro. Although the underlying mechanism is not clear, this observation is consistent with published reports showing that CD8 + T cells are more responsive to IL-7 than CD4 + T cells in in vitro cultures 9 . Nevertheless, we have shown that naive CD4 + T cells in which Foxp1 was acutely deleted had proliferation in intact recipient mice similar to that of Foxp1-deficient naive CD8 + T cells, which indicates that Foxp1 controls T cell quiescence in both CD4 + and CD8 + T cells in vivo. In summary, our results have shown that Foxp1 exerts essential cell-intrinsic transcriptional regulation on the quiescence and homeostasis of naive T cells by negatively regulating IL-7Rα expression and MEK-Erk signaling. Our findings have demonstrated coordinated regulation that actively inhibits T cell activation signals and indicate that lymphocyte quiescence does not occur by default but is actively maintained.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
